Advertisement

Journal of Pharmaceutical Investigation

, Volume 49, Issue 1, pp 57–65 | Cite as

Physicochemical characterization and cytotoxicity of chitosan-modified single walled carbon nanotubes as drug carriers

  • Xiao-Xue Zhang
  • Hao-Yan Huang
  • Li-Qing Chen
  • Hehua Jin
  • Beom-Jin Lee
  • Jing-Hao Cui
  • Qing-Ri CaoEmail author
Original Paper
  • 57 Downloads

Abstract

The application of single-walled carbon nanotubes (SWCNTs) as drug carriers is limited by their poor dispersal in aqueous medium. This study aimed to prepare chitosan (CS)-modified SWCNTs (CS-SWCNTs) and to evaluate their physicochemical properties and cytotoxicity. Oxidized SWCNTs (O-SWCNTs) were prepared with the use of strong acid, and the effects of acidizing conditions on the oxidation degree of the O-SWCNTs were investigated. CS was then non-covalently modified on the surfaces of O-SWCNTs. O-SWCNTs and CS-SWCNTs were characterized through ultraviolet spectroscopy, Fourier transform-infrared spectroscopy, Raman spectroscopy, and transmission electron microscopy. The cytotoxic effects of the functionalized SWCNTs were determined through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. O-SWCNTs with relatively complete structure were successfully synthesized through 5 h of treatment with 5 M acid. The amine group of the CS and the carboxyl group of O-SWCNTs interacted in CS-SWCNTs. The functionalized SWCNTs did not aggregate or precipitate in water and exerted no cytotoxic effects on A549 and MCF-7 tumor cells. The CS-SWCNTs possess the advantages of a simple preparation process, excellent water dispersibility, and biocompatibility for drug loading.

Keywords

Carbon nanotubes Chitosan TEM Raman spectroscopy X-ray diffraction Cytotoxicity 

Notes

Acknowledgements

This work was partially supported by the National Natural Science Foundation of China (81373333, 21373262), and a Project Funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions.

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

Statement of human and animal rights

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

  1. Bernkop-Schnürch A, Dünnhaupt S (2012) Chitosan-based drug delivery systems. Eur J Pharm Biopharm 81(3):463–469CrossRefGoogle Scholar
  2. Bhumkar DR, Joshi HM, Sastry M, Pokharkar VB (2007) Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm Res 24(8):1415–1426CrossRefGoogle Scholar
  3. Bota P, Dorobantu D, Boerasu I, Bojin D, Enachescu M (2014) Synthesis of single-wall carbon nanotubes by excimer laser ablation. Surf Eng Appl Electrochem 50(4):294–299CrossRefGoogle Scholar
  4. Carson L, Kelly-Brown C, Stewart M, Oki A, Regisford G, Luo ZP, Bakhmutov IV (2009) Synthesis and characterization of chitosan-carbon nanotube composites. Mater Lett 63(6–7):617–620CrossRefGoogle Scholar
  5. Carson L, Kelly-Brown C, Stewart M, Oki A, Regisford G, Stone G, Traisawatwong P, Durand-Rougely C, Luo ZP (2010) Grafting of chitosan and chitosantrimethoxylsilylpropyl methacrylate on single walled carbon nanotubes-synthesis and characterization. J Chem Chem Eng 4(9):6–13Google Scholar
  6. Chattopadhyay S, Dash SK, Mahapatra SK, Tripathy S, Ghosh T, Das B, Das D, Pramanik P, Roy S (2014) Chitosan-modified cobalt oxide nanoparticles stimulate TNF-α-mediated apoptosis in human leukemic cells. J Biol Inorg Chem 19(3):399–414CrossRefGoogle Scholar
  7. Chen RJ, Zhang Y, Wang D, Dai H (2001) Noncovalent sidewall functionalization of single-walled carbon nanotubes for protein immobilization. J Am Chem Soc 123(16):3838–3839CrossRefGoogle Scholar
  8. Cover NF, Lai-Yuen S, Parsons AK, Kumar A (2012) Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy. Int J Nanomed 7:2411–2419Google Scholar
  9. Dresselhaus MS, Jorio A, Souza Filho AG, Saito R (2010) Defect characterization in graphene and carbon nanotubes using Raman spectroscopy. Philos Trans A 368(1932):5355–5377CrossRefGoogle Scholar
  10. Eatemadi A, Daraee H, Karimkhanloo H, Kouhi M, Zarghami N, Akbarzadeh A, Abasi M, Hanifehpour Y, Joo SW (2014) Carbon nanotubes: properties, synthesis, purification, and medical applications. Nanoscale Res Lett 9(1):393CrossRefGoogle Scholar
  11. He H, Pham-Huy LA, Dramou P, Xiao D, Zuo P, Pham-Huy C (2013) Carbon nanotubes: applications in pharmacy and medicine. Biomed Res Int 2013:578290Google Scholar
  12. Huo M, Zhang Y, Zhou J, Zou A, Yu D, Wu Y, Li J, Li H (2010) Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug. Int J Pharm 394(1–2):162–173CrossRefGoogle Scholar
  13. Karimi M, Avci P, Mobasseri R, Hamblin MR, Naderi-Manesh H (2013) The novel albumin-chitosan core-shell nanoparticles for gene delivery: preparation, optimization and cell uptake investigation. J Nanopart Res 15(4):1651CrossRefGoogle Scholar
  14. Karimi M, Solati N, Amiri M, Mirshekari H, Mohamed E, Taheri M, Hashemkhani M, Saeidi A, Estiar MA, Kiani P, Ghasemi A, Basri SM, Aref AR, Hamblin MR (2015) Carbon nanotubes part I: preparation of a novel and versatile drug-delivery vehicle. Expert Opin Drug Deliv 12(7):1071–1087CrossRefGoogle Scholar
  15. Kovtyukhova NI, Mallouk TE, Pan L, Dickey EC (2003) Individual single-walled nanotubes and hydrogels made by oxidative exfoliation of carbon nanotube ropes. J Am Chem Soc 125(32):9761–9769CrossRefGoogle Scholar
  16. Liao XX, Zhang XW (2011) Preparation, characterization and cytotoxicity of carbon nanotube-chitosan-phycocyanin complex. Nanotechnology 23(3):035101CrossRefGoogle Scholar
  17. Lu W, Zu M, Byun JH, Kim BS, Chou TW (2012) State of the art of carbon nanotube fibers: opportunities and challenges. Adv Mater 24(14):1805–1833CrossRefGoogle Scholar
  18. Madani SY, Tan A, Dwek M, Seifalian AM (2012) Functionalization of single-walled carbon nanotubes and their binding to cancer cells. Int J Nanomed 7:905–914Google Scholar
  19. Mubarak NM, Abdullah EC, Jayakumar NS, Sahu JN (2014) An overview on methods for the production of carbon nanotubes. J Ind Eng Chem 20(4):1186–1197CrossRefGoogle Scholar
  20. Peretz S, Regev O (2012) Carbon nanotubes as nanocarriers in medicine. Curr Opin Colloid Interface Sci 17(6):360–368CrossRefGoogle Scholar
  21. Rastogi V, Yadav P, Bhattacharya SS, Mishra AK, Verma N, Verma A, Pandit JK (2014) Carbon nanotubes: an emerging drug carrier for targeting cancer cells. J Drug Deliv 2014:670815CrossRefGoogle Scholar
  22. Su Y, Wei H, Li T, Geng H, Zhang Y (2014) Low-cost synthesis of single-walled carbon nanotubes by low-pressure air arc discharge. Mater Res Bull 50:23–25CrossRefGoogle Scholar
  23. Sui Z, Meng Q, Zhang X, Ma R, Cao B (2012) Green synthesis of carbon nanotube-graphene hybrid aerogels and their use as versatile agents for water purification. J Mater Chem 22(18):8767–8771CrossRefGoogle Scholar
  24. Tarek AA, Bader MA (2016) Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery. Drug Des Devel Ther 10:483–507Google Scholar
  25. Tiyaboonchai W (2003) Chitosan nanoparticles: a promising system for drug delivery. Naresuan Univ J 11(3):51–66Google Scholar
  26. Zhang YL, Hou PX, Liu C, Cheng HM (2014) De-bundling of single-wall carbon nanotubes induced by an electric field during arc discharge synthesis. Carbon 74:370–373CrossRefGoogle Scholar
  27. Zhou F, Xing D, Ou Z, Wu B, Resasco DE, Chen WR (2009) Cancer photothermal therapy in the near-infrared region by using single-walled carbon nanotubes. J Biomed Opt 14(2):021009CrossRefGoogle Scholar

Copyright information

© The Korean Society of Pharmaceutical Sciences and Technology 2018

Authors and Affiliations

  • Xiao-Xue Zhang
    • 1
  • Hao-Yan Huang
    • 1
  • Li-Qing Chen
    • 1
  • Hehua Jin
    • 2
  • Beom-Jin Lee
    • 3
  • Jing-Hao Cui
    • 1
  • Qing-Ri Cao
    • 1
    Email author
  1. 1.College of Pharmaceutical SciencesSoochow UniversitySuzhouPeople’s Republic of China
  2. 2.Key Laboratory of Nanodevices and Applications, Suzhou Institute of Nanotech and NanobionicsChinese Academy of ScienceSuzhouPeople’s Republic of China
  3. 3.College of PharmacyAjou UniversitySuwonRepublic of Korea

Personalised recommendations